Glenmark enters oncology segment
GBR 1302 is Glenmark’s first clinical candidate targeting oncology indications
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Claris Lifesciences gets UK MHRA approval for plant 2
Claris Lifesciences received the UK MHRA approval for its newly commissioned plant (Plant 2)
IPM clocks Rs 7161 crores in July 2014
From therapy perspective, 12 therapies have outgrown the IPM growth
Pharmexcil to celebrate 10th annual meet with host of events
Minister of Commerce, Government of India, senior officials from Department of Commerce, Pharmaceuticals, Health, DCG(I), Science…
Lex Witness to host 3rd annual edition of The Pharma Legal & Compliance Summit
The summit will be an initiative to cut through legal and regulatory challenges being faced by the Indian pharma industry
Asia Pharma Expo 2015 to be held in Bangladesh
More than 470 exhibiting companies from 28 countries will participate
Adding bite to DCG(I)’s bark
On August 6, the quality assurance (QA) division of the CDSCO had released guidelines on the procedures to be followed by its…
Wockhardt’s infective drugs receive QIDP status from US FDA
WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tablet
Piramal Enterprises and Navin Fluorine International to form JV company
To develop, manufacture and sell speciality fluorochemicals with specific focus on applications in healthcare